Mark D. Preston

Mark D. Preston

Auto-generated profile, based on publicly available information

Mark D. Preston

National Institute for Biological Standards and Controls, Potters Bar, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2015 in Genome Medicine
Verified
Journal Article
Open access
PDF file
FCFrancesc Coll
Francesc Coll
RMRuth Mcnerney
Ruth Mcnerney
MPMark D Preston
Mark D Preston
JGJosé Afonso Guerra-Assunção
José Afonso Guerra-Assunção
AWAndrew Warry
Andrew Warry
Taane ClarkTaane Clark
Taane Clark
Mycobacterium tuberculosis drug resistance (DR) challenges effective tuberculosis disease control. Current molecular tests examine limited numbers of mutations, and although whole genome sequencing approaches could fully characterise DR, data complexity has restricted their clinical application. A library (1,325 mutations) predictive of DR for 15 anti-tuberculosis drugs was compiled and validated for 11 of them using genomic-phenotypic data from 792 strains. A rapid online ‘TB-Profiler’ tool was developed to report DR and strain-type profiles directly from raw sequences. Using our DR mutation library, in silico diagnostic accuracy was superior to some commercial diagnostics and alternative databases. The library will facilitate sequence-based drug-susceptibility testing.

13 June 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMark D. Preston
Mark D. Preston
SCSusana Campino
Susana Campino
SASamuel A. Assefa
Samuel A. Assefa
DEDiego F. Echeverry
Diego F. Echeverry
HOHarold Ocholla
Harold Ocholla
Taane ClarkTaane Clark
Taane Clark
Malaria is a major public health problem that is actively being addressed in a global eradication campaign. Increased population mobility through international air travel has elevated the risk of re-introducing parasites to elimination areas and dispersing drug-resistant parasites to new regions. A simple genetic marker that quickly and accurately identifies the geographic origin of infections would be a valuable public health tool for locating the source of imported outbreaks. Here we analyse the mitochondrion and apicoplast genomes of 711 Plasmodium falciparum isolates from 14 countries, and find evidence that they are non-recombining and co-inherited. The high degree of linkage produces a panel of relatively few single-nucleotide polymorphisms (SNPs) that is geographically informative. We design a 23-SNP barcode that is highly predictive (~92%) and easily adapted to aid case management in the field and survey parasite migration worldwide.

25 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IZIrina T. Zaharieva
Irina T. Zaharieva
MCMattia Calissano
Mattia Calissano
MSMariacristina Scoto
Mariacristina Scoto
MPMark Preston
Mark Preston
SCSebahattin Cirak
Sebahattin Cirak
FMFrancesco Muntoni
Francesco Muntoni
Duchenne muscular Dystrophy (DMD) is an inherited disease caused by mutations in the dystrophin gene that disrupt the open reading frame, while in frame mutations result in Becker muscular dystrophy (BMD). Ullrich congenital muscular dystrophy (UCMD) is due to mutations affecting collagen VI genes. Specific muscle miRNAs (dystromirs) are potential non-invasive biomarkers for monitoring the outcome of therapeutic interventions and disease progression. We quantified miR-1, miR-133a,b, miR-206 and miR-31 in serum from patients with DMD, BMD, UCMD and healthy controls. MiR-1, miR-133a,b and miR-206 were upregulated in DMD, but unchanged in UCMD compared to controls. Milder DMD patients had higher levels of dystromirs than more severely affected patients. Patients with low forced vital capacity (FVC) values, indicating respiratory muscle weakness, had low levels of serum miR-1 and miR-133b. There was no significant difference in the level of the dystromirs in BMD compared to controls. We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene. The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial. Our analysis detected a trend towards normalization of these miRNA between the pre- and post-treatment samples of the systemic trial, which however failed to reach statistical significance. This could possibly be due to the small number of patients and the short duration of these clinical trials. Although longer term studies are needed to clarify the relationship between dystrophin restoration following therapeutic intervention and the level of circulating miRNAs, our results indicate that miR-1 and miR-133 can be considered as exploratory biomarkers for monitoring the progression of muscle weakness and indirectly the remaining muscle mass in DMD.

12 September 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
IPIan J Passmore
Ian J Passmore
MLMarine P M Letertre
Marine P M Letertre
MPMark D Preston
Mark D Preston
IBIrene Bianconi
Irene Bianconi
MHMark A Harrison
Mark A Harrison
LDLisa F Dawson
Lisa F Dawson
Clostridium difficile is a Gram-positive spore-forming anaerobe and a major cause of antibiotic-associated diarrhoea. Disruption of the commensal microbiota, such as through treatment with broad-spectrum antibiotics, is a critical precursor for colonisation by C. difficile and subsequent disease. Furthermore, failure of the gut microbiota to recover colonisation resistance can result in recurrence of infection. An unusual characteristic of C. difficile among gut bacteria is its ability to produce the bacteriostatic compound para-cresol (p-cresol) through fermentation of tyrosine. Here, we demonstrate that the ability of C. difficile to produce p-cresol in vitro provides a competitive advantage over gut bacteria including Escherichia coli, Klebsiella oxytoca and Bacteroides thetaiotaomicron. Metabolic profiling of competitive co-cultures revealed that acetate, alanine, butyrate, isobutyrate, p-cresol and p-hydroxyphenylacetate were the main metabolites responsible for differentiating the parent strain C. difficile (630Δerm) from a defined mutant deficient in p-cresol production. Moreover, we show that the p-cresol mutant displays a fitness defect in a mouse relapse model of C. difficile infection (CDI). Analysis of the microbiome from this mouse model of CDI demonstrates that colonisation by the p-cresol mutant results in a distinctly altered intestinal microbiota, and metabolic profile, with a greater representation of Gammaproteobacteria, including the Pseudomonales and Enterobacteriales. We demonstrate that Gammaproteobacteria are susceptible to exogenous p-cresol in vitro and that there is a clear divide between bacterial Phyla and their susceptibility to p-cresol. In general, Gram-negative species were relatively sensitive to p-cresol, whereas Gram-positive species were more tolerant. This study demonstrates that production of p-cresol by C. difficile has an effect on the viability of intestinal bacteria as well as the major metabolites produced in vitro. These observations are upheld in a mouse model of CDI, in which p-cresol production affects the biodiversity of gut microbiota and faecal metabolite profiles, suggesting that p-cresol production contributes to C. difficile survival and pathogenesis. Clostridium difficile is a bacterium responsible for causing the majority of antibiotic associated diarrhoea outbreaks world-wide. In the United States of America, C. difficile infects half a million people annually. Antibiotics disrupt the natural protective gut microbiota, rendering people susceptible to C. difficile infection, which leads to potentially life-threatening disease and complications. C. difficile is transmitted by spores, which are able to survive in harsh environments for long periods of time. After initial treatment for C. difficile, up to 35% of patients develop the disease again, thus requiring additional and more successful treatment. Here, we use novel techniques to show that C. difficile produces a compound, p-cresol, which has detrimental effects on the natural protective gut bacteria. We show that p-cresol selectively targets certain bacteria in the gut and disrupts their ability to grow. By removing the ability of C. difficile to produce p-cresol, we show that it makes C. difficile less able to recolonise after an initial infection. This is linked to significant alterations in the natural healthy bacterial composition of the gut. Our study provides new insights into the effects of p-cresol production on the healthy gut microbiota and how it contributes to C. difficile survival and pathogenesis.

26 September 2012 in Bioinformatics
Verified
Journal Article
Open access
PDF file
FCFrancesc Coll
Francesc Coll
KMKim Mallard
Kim Mallard
MPMark D. Preston
Mark D. Preston
SBStephen Bentley
Stephen Bentley
JPJulian Parkhill
Julian Parkhill
Taane ClarkTaane Clark
Taane Clark
Summary: Spoligotyping is a well-established genotyping technique based on the presence of unique DNA sequences in Mycobacterium tuberculosis (Mtb), the causal agent of tuberculosis disease (TB). Although advances in sequencing technologies are leading to whole-genome bacterial characterization, tens of thousands of isolates have been spoligotyped, giving a global view of Mtb strain diversity. To bridge the gap, we have developed SpolPred, a software to predict the spoligotype from raw sequence reads. Our approach is compared with experimentally and de novo assembly determined strain types in a set of 44 Mtb isolates. In silico and experimental results are identical for almost all isolates (39/44). However, SpolPred detected five experimentally false spoligotypes and was more accurate and faster than the assembling strategy. Application of SpolPred to an additional seven isolates with no laboratory data led to types that clustered with identical experimental types in a phylogenetic analysis using single-nucleotide polymorphisms. Our results demonstrate the usefulness of the tool and its role in revealing experimental limitations. Availability and implementation: SpolPred is written in C and is available from www.pathogenseq.org/spolpred. Contact:francesc.coll@lshtm.ac.uk Supplementary information: Supplementary data are available at Bioinformatics Online.

5 October 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SASamuel Assefa
Samuel Assefa
CLCaeul Lim
Caeul Lim
MPMark D. Preston
Mark D. Preston
CDCraig W. Duffy
Craig W. Duffy
MNMridul B. Nair
Mridul B. Nair
BSBalbir Singh
Balbir Singh
Significance: Genome sequence analysis reveals that the zoonotic malaria parasite Plasmodium knowlesi consists of three highly divergent subpopulations. Two, commonly seen in sympatric human clinical infections in Malaysian Borneo, were identified in a previous study as corresponding to parasites seen in long-tailed and pig-tailed macaque hosts, respectively. A third type has been detected in a few laboratory-maintained isolates originally derived in the 1960s elsewhere in Southeast Asia. Divergence between the subpopulations varies significantly across the genome but overall is at a level indicating different subspecies. Analysis of the diversity within the most common type in human infections shows strong signatures of natural selection, including balancing selection and directional selection, on loci distinct from those under selection in endemic human malaria parasites.